OncView Podcast: Optimizing Treatment With Extended Adjuvant Therapy for HR+ Breast Cancer
In this special edition of the “Oncology Peer Review On-The-Go” podcast, CancerNetwork spoke with Reshma L. Mahtani, DO, about genomic testing to optimize treatment outcomes in HR-positive breast cancer.
As part of its OncView video series, CancerNetwork spoke with Reshma L. Mahtani, DO, Sylvester Comprehensive Cancer Center, about the current role of genomic testing in HR-positive breast cancer and guidance on the use of genomic assays to individualize therapy in the extended adjuvant setting.
In the video series, Mahtani discussed the following:
- Extended Adjuvant Therapy for HR+ Breast Cancer
- NCCN Updates to Genomic Testing in HR+ Breast Cancer
- Genomic Testing for HR+ Breast Cancer: Best Practices
- Utilization of The Breast Cancer Index for HR+ Breast Cancer
- Optimizing Treatment Outcomes in HR+ Breast Cancer
To watch more videos in CancerNetwork’s OncView series, visit cancernetwork.com.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Elevating the Quality of Cancer Care via Cross-Department Collaboration
Experts from Sibley Memorial Hospital discuss how multidisciplinary work has enhanced outcomes such as survival and resource use at their institution.
